Darnell A. Pouncil

Array ( [id] => 6270339 [patent_doc_number] => 20100254938 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-07 [patent_title] => 'FORMULATION HAVING MOBILISING ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/755321 [patent_app_country] => US [patent_app_date] => 2010-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 2538 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20100254938.pdf [firstpage_image] =>[orig_patent_app_number] => 12755321 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8138419 [patent_doc_number] => 20120093761 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'VACCINE COMPOSITIONS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/262285 [patent_app_country] => US [patent_app_date] => 2010-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 20953 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20120093761.pdf [firstpage_image] =>[orig_patent_app_number] => 13262285 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7738103 [patent_doc_number] => 20120018338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-26 [patent_title] => 'METHOD FOR AVOIDING GLASS FOGGING' [patent_app_type] => utility [patent_app_number] => 13/262603 [patent_app_country] => US [patent_app_date] => 2010-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6194 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20120018338.pdf [firstpage_image] =>[orig_patent_app_number] => 13262603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6500317 [patent_doc_number] => 20100215667 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'METHODS AND COMPOSITIONS OF TREATMENT FOR MODULATING THE IMMUNE SYSTEM OF ANIMALS' [patent_app_type] => utility [patent_app_number] => 12/723440 [patent_app_country] => US [patent_app_date] => 2010-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 13333 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20100215667.pdf [firstpage_image] =>[orig_patent_app_number] => 12723440 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12526962 [patent_doc_number] => 10005830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-06-26 [patent_title] => Antigen binding dimer-complexes, methods of making/avoiding and uses thereof [patent_app_type] => utility [patent_app_number] => 13/254266 [patent_app_country] => US [patent_app_date] => 2010-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 40 [patent_no_of_words] => 43879 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13254266 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10013091 [patent_doc_number] => 09056095 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-16 [patent_title] => 'Immunogenic composition' [patent_app_type] => utility [patent_app_number] => 13/202336 [patent_app_country] => US [patent_app_date] => 2010-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 15261 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13202336 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636332 [patent_doc_number] => 20100226953 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-09 [patent_title] => 'MEDICAL DEVICES HAVING A COATING OF BIOLOGIC MACROMOLECULES' [patent_app_type] => utility [patent_app_number] => 12/708993 [patent_app_country] => US [patent_app_date] => 2010-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3038 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0226/20100226953.pdf [firstpage_image] =>[orig_patent_app_number] => 12708993 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8363832 [patent_doc_number] => 08252898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-28 [patent_title] => 'Defensin-encoding nucleic acid molecules derived from Nicotiana alata, uses therefor and transgenic plants comprising same' [patent_app_type] => utility [patent_app_number] => 12/708421 [patent_app_country] => US [patent_app_date] => 2010-02-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 22 [patent_no_of_words] => 25571 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12708421 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8495458 [patent_doc_number] => 20120294866 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-22 [patent_title] => 'PHARMACEUTICAL FORMULATION FOR PROTEINS' [patent_app_type] => utility [patent_app_number] => 13/574071 [patent_app_country] => US [patent_app_date] => 2010-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3693 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13574071 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7669063 [patent_doc_number] => 20110318332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-12-29 [patent_title] => 'IMMUNOGLOBULIN G COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/139821 [patent_app_country] => US [patent_app_date] => 2009-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4659 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13139821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8264707 [patent_doc_number] => 20120164135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-28 [patent_title] => 'METHOD FOR PREPARING COMPREHENSIVE ANTI-SURFACE ANTIBODY USING MICROORGANISM IMMOBILIZED AS ANTIGEN WITH PROTEIN CROSSLINKING AND IMMOBILIZATION REAGENT' [patent_app_type] => utility [patent_app_number] => 13/141009 [patent_app_country] => US [patent_app_date] => 2009-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5369 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13141009 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10580963 [patent_doc_number] => 09303082 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-04-05 [patent_title] => 'Immunogenic polypeptides comprising a scaffold polypeptide and a L2 polypeptide or a fragment thereof' [patent_app_type] => utility [patent_app_number] => 13/140793 [patent_app_country] => US [patent_app_date] => 2009-12-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 12719 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13140793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6289936 [patent_doc_number] => 20100158919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-06-24 [patent_title] => 'Pharmaceutical Composition' [patent_app_type] => utility [patent_app_number] => 12/636964 [patent_app_country] => US [patent_app_date] => 2009-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9098 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0158/20100158919.pdf [firstpage_image] =>[orig_patent_app_number] => 12636964 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725129 [patent_doc_number] => 08404243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Peptide adjuvants' [patent_app_type] => utility [patent_app_number] => 13/129514 [patent_app_country] => US [patent_app_date] => 2009-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 20 [patent_no_of_words] => 7866 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13129514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6626052 [patent_doc_number] => 20100172862 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-08 [patent_title] => 'STABLE ANTIBODY COMPOSITIONS AND METHODS OF STABILIZING SAME' [patent_app_type] => utility [patent_app_number] => 12/625057 [patent_app_country] => US [patent_app_date] => 2009-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 41148 [patent_no_of_claims] => 144 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0172/20100172862.pdf [firstpage_image] =>[orig_patent_app_number] => 12625057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7510155 [patent_doc_number] => 20110256214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-20 [patent_title] => 'SINGLE-TIME VACCINES' [patent_app_type] => utility [patent_app_number] => 13/130146 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16727 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0256/20110256214.pdf [firstpage_image] =>[orig_patent_app_number] => 13130146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754628 [patent_doc_number] => 20120027772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'THERAPEUTIC PROTEIN FORMULATIONS' [patent_app_type] => utility [patent_app_number] => 13/130277 [patent_app_country] => US [patent_app_date] => 2009-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 23892 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027772.pdf [firstpage_image] =>[orig_patent_app_number] => 13130277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6392079 [patent_doc_number] => 20100303823 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'HUMAN MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN 8 (IL-8)' [patent_app_type] => utility [patent_app_number] => 12/616615 [patent_app_country] => US [patent_app_date] => 2009-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 27305 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303823.pdf [firstpage_image] =>[orig_patent_app_number] => 12616615 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7586354 [patent_doc_number] => 20110280864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'Low Viscosity Highly Concentrated Suspensions' [patent_app_type] => utility [patent_app_number] => 13/129283 [patent_app_country] => US [patent_app_date] => 2009-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19683 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20110280864.pdf [firstpage_image] =>[orig_patent_app_number] => 13129283 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6314392 [patent_doc_number] => 20100111985 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'VACCINE COMPOSITIONS AND METHODS OF USE' [patent_app_type] => utility [patent_app_number] => 12/610964 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5386 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0111/20100111985.pdf [firstpage_image] =>[orig_patent_app_number] => 12610964 [rel_patent_id] =>[rel_patent_doc_number] =>)